VPVirginia Pascual-Ramos

Virginia Pascual-Ramos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Virginia Pascual-Ramos has a total of 406 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Higher Daily Hospitalization Costs and Intensive Care Utilization Among Decedents With Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Bioethical Analysis of End‐of‐Life Care

    by Guillermo Arturo Guaracha‐Basañez, Irazú Contreras‐Yáñez, Julia Giselle Jiménez‐Decle, Laura Viviana Vargas‐Sánchez, Abril Verónica Mendoza‐Vigueras, Frida Carvajal‐Medina, Mariana Lourdes López‐Ávila, Raúl Rivera‐Moscoso, Virginia Pascual‐Ramos

    Introduction: End‐of‐life care creates financial burdens. This study examines medical procedures/interventions and costs for inpatients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), comparing those who died during hospitalization to those who survived, analyzing the findings through a bioethical perspective. Methods: This observational 1:1 case‐control study was conducted at a tertiary care center. Patients with SLE and RA (ICD‐10‐CM diagnostic codes) who were hospitalized for at least 24 h during two distinct periods—January–June 2019 and January–June 2023—were included. Patients were designated as cases if they died during hospitalization and as controls if they were discharged alive. Data were abstracted from electronic medical records using standardized formats. Microcosting data for each hospitalization were obtained from the accounting department. Results: We identified 29 matched pairs of cases and controls, primarily comprising middle‐aged females, with SLE. Cases and controls had similar sociodemographic and disease‐related characteristics. However, cases spent a greater proportion of their hospitalization time in the intensive care unit (100% [33.9–100] vs. 27.5% [13.4–45], p ≤ 0.001) and had higher incidence of complications (75.9% vs. 34.5%, p = 0.003). Daily hospitalization costs were significantly higher for cases (USD 3348 vs. 2707.4, p = < 0.001). More cases utilized blood bank services, while fewer engaged in clinical nutrition‐related procedures. Conclusions: Decedents with SLE/RA had higher daily hospitalization costs than matched survivors, in the context of greater ICU utilization, complications, and blood bank use. End‐of‐life scenarios are complex; clinical decisions should be examined through bioethical lens.

  • Prevalence and transient impact of childhood abuse and neglect on health-related quality of life in Mexican patients with early rheumatoid arthritis

    by Guillermo Guaracha-Basáñez, Irazú Contreras-Yáñez, Abril Verónica Mendoza-Vigueras, Frida Carvajal-Medina, Ana Belén Ortiz-Haro, Loraine Ledón-Llanes, Virginia Pascual-Ramos

  • Diagnostic delay in psoriatic disease: cutaneous and musculoskeletal pathways in a Mexican tertiary-care cohort

    by Guaracha- Basañez, Guillermo Arturo, Irazú Contreras-Yáñez, Silvia Méndez-Flores, Pérez- Gamboa, Raúl, García- Herrera, Iris Paola, Virginia Pascual-Ramos

  • Promoting the utilization of rheumatologic musculoskeletal anatomy: a 50-year travel log

    by Robert A. Kalish, Jeffrey R. Wohlgethan, Nancy Liu, José Alvarez Nemegyei, Pablo Villaseñor-Ovies, Miguel Ángel Saavedra, Cristina Hernández-Díaz, José Eduardo Navarro-Zarza, Virginia Pascual-Ramos, Esperanza Naredo, et al.

    This report traces the authors' long journey toward a deeper understanding of the anatomical basis of rheumatologic physical examination. Fifty years ago, one of the authors was struck by the prevalence of subcutaneous and deep bursitis and regional musculoskeletal pain syndromes at his new workplace, prompting studies of bursal swelling, lubrication, and the dynamics of distended superficial and deep bursae. Subsequently, a deficiency in anatomical knowledge was noted across multiple workshops at the American College of Rheumatology and elsewhere. Later, in a different setting, musculoskeletal anatomy workshops were held, based on cross-examination between rheumatology learners and instructors. Palpation was used in the upper extremity, and the spine and lower extremity were demonstrated through motion and self-palpation. Pre-workshop tests consistently revealed poor recall of musculoskeletal anatomy among trainees and practitioners, including orthopedic trainees. All questions were rated highly important in an international Delphi survey of anatomical items relevant to rheumatology. Subsequently, a self-examination method was developed to allow learners to practice, in privacy, the anatomical knowledge traditionally acquired. More recently, an international, unfunded, and enthusiastic study group comprising anatomists, rheumatologists, and ultrasonographers made independent observations of defined neck and upper extremity structures, including the elusive lower belly of omohyoid, the dorsal forearm muscle-tendon intersection, the concurrent contraction of anconeus and pronator teres, and dynamic aspects of the extensor apparatus of the fingers, the natatory ligament, the web spaces, and the intertendinous connections. In these studies, physical examination and ultrasound complemented each other. Thus, physical examination, rather than being replaced, should be strengthened. Key Points • We describe a sustained effort spanning more than 50 years to reinstate MSK anatomy as a basic competence for MSK conditions and general rheumatologic examination. • The initial studies focused on subcutaneous and deep bursae and on seminars regarding musculoskeletal pain syndromes and, much later, the anatomical basis of rheumatologic examination. • This was followed by a one-on-one assessment of rheumatology fellows' and practitioners' anatomical knowledge and by participatory MSK anatomy seminars held across the Americas with support from ILAR. • Subsequently, a method of self-examination was developed as an accessible way to reinforce anatomical learning. • Currently, independent physical examination and ultrasonography, along with dissection performed by anatomists, have resulted in a series of innovative and fruitful proof-of-concept studies.

  • Open Access

    Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis

    by George A Karpouzas, Miguel A Gonzalez-Gay, Virginia Pascual-Ramos, Durga Prasanna Misra, Elena Myasoedova, Solbritt Rantapää-Dahlqvist, Petros Sfikakis, Patrick Dessein, Carol A Hitchon, Dionicio Galarza-Delgado, et al.

    Objectives: Rheumatoid factor (RF) and anticitrullinated protein antibodies (ACPA) are linked to disease activity, severity and cardiovascular risk in rheumatoid arthritis (RA). Since RA-related inflammation associates with cardiovascular disease, we investigated whether RF and ACPA status influence the relationship between RA activity and event risk. Methods: We assessed 3952 cardiovascular disease-free patients with prevalent RA registered in an international observational consortium between 1985 and 2012. Main outcome was a first major adverse cardiovascular event (MACE) including myocardial infarction, stroke and cardiovascular death. Follow-up accrued from enrolment until first MACE or censoring. Multivariable Cox models stratified by centre risk evaluated disease activity, RF, ACPA and their interactions. Results: We recorded 184 first MACE events over 22 981 patient-years. Disease activity associated with MACE (HR 1.18 (95% CI 1.03 to 1.35)), whereas RF (HR 1.26 (0.82 to 1.94)) and ACPA (HR 1.25 (0.85 to 1.83)) did not reach statistical significance, though CIs were wide and a clinically meaningful association cannot be excluded. A three-way interaction between disease activity, RF and ACPA on MACE (p for interaction=0.044) was observed. RA activity associated with MACE in seronegative and double seropositive (p≤0.047), but not single RF-positive or ACPA-positive patients. Among RF-negative participants, RA activity was linked to MACE in ACPA-negative but not positive ones (p for interaction=0.003). Among ACPA-positive patients, disease activity was linked to MACE in RF-positive but not RF-negative ones (p for interaction=0.040). Conclusions: Disease activity may better discriminate inflammation-driven cardiovascular risk in seronegative and double seropositive than single RF-positive or ACPA-positive patients. Risk protection through lowering disease activity may be serostatus dependent.

  • Protective effect of antimalarials on the most frequently affected damage domains in SLE: Data from a multiethnic Latin American cohort

    by Rosana Quintana, Guillermo J. Pons-Estel, Daniel Wojdyla, Graciela S. Alarcón, Rosa María Serrano, Manuel Ugarte-Gil, Víctor Pimentel-Quiroz, Luis J. Catoggio, Marina Scolnik, Mónica Sacnun, et al.

    Objective: To assess the effect of antimalarials (AMs) on overall damage and on its most frequently affected domains, as measured by the Systemic Lupus International Collaborating Clinics Damage Index (SDI) in patients from the GLADEL cohort. Methods: New damage was defined as a ≥1 point increase in SDI since cohort entry. AMs users were those who received AMs for at least 6 months after entering the cohort. AMs users and non-users were matched for age, sex, ethnicity, and baseline SDI using stratified random sampling. Two comparisons were carried out: patients with and without new damage, and AM users versus non-users. Propensity score matching was used to determine the effect of AM use on the most frequently affected damage domains. Results: A total of 850 patients were included; 419 (49.3%) were AM users and 431 (50.7%) non-users. During a median follow-up of 48.5 (IQR 19.3, 69.0) months, 472 (55.5%) developed damage. The most affected domains were skin (18.4%), renal (14.6%), neuropsychiatric (10.8%), musculoskeletal (6.9%), and cardiovascular (4.5%). AMs use was associated with a lower proportion of patients accruing damage at follow-up (170 [40.6%] vs 208 [48.3%]; p = .028). AMs were protective against overall damage (HR 0.7, 95% CI [0.5–0.9]; p = .002), renal (HR 0.4, 95% CI [0.3–0.6]; p < .001), and neuropsychiatric damage (HR 0.5, 95% CI [0.3–0.9]; p = .022). Conclusion: AM use is independently associated with a lower probability of overall, renal, and neuropsychiatric damage accrual. These findings support early and sustained AM treatment in lupus patients, unless contraindicated.

  • Sex Differences in Quality of Life Related to Nail Psoriasis Among Patients With Psoriatic Disease

    by Guillermo Arturo Guaracha-Basañez, Iris Paola García-Herrera, Silvia Mendez-Flores, Diana Marcela Padilla-Ortiz, Irazú Contreras-Yáñez, Virginia Pascual-Ramos

    Background: Nail psoriasis (NPso) affects around 70% of patients with psoriatic disease (PD), affecting the aesthetic, psychological, and functional aspects of their lives. Despite its burden, sex differences in quality of life related to nail psoriasis (QoL-NPso) remain underexplored. Objectives: The study aimed to compare QoL-NPso between female and male patients with PD and to examine the interaction between sex and QoL-NPso in relevant patient-reported outcomes (PROs). Methods: We conducted a cross-sectional analysis nested within IMPACTO, a prospective PD cohort at a tertiary academic center. NPso was assessed using the Nail Psoriasis Severity Index (NAPSI), and QoL-NPso was measured with the Nail Psoriasis Quality of Life questionnaire. PROs included the WHOQoL-BREF, HAQ-DI, and HADS. Interaction analyses evaluated the combined effect of sex and QoL-NPso on PROs, adjusting for relevant sociodemographic and clinical covariates. The institutional ethics committee approved the study. Results: The study included 77 PD patients; NPso was present in 66%. Women exhibited longer disease duration ( p =0.03), higher disease activity ( p =0.02), more years of formal education ( p =0.02), and lower rates of paid employment ( p =0.003). QoL-NPso was associated with lower physical, psychological, and social QoL scores, as well as higher disability, depression, and anxiety scores. These associations were significant in women but not in men. Interaction analysis revealed that women in the highest QoL-NPso tertile experienced significantly worse scores across the PROs than men. Conclusions: Sex modified the impact of NPso on PROs, with women experiencing greater psychosocial distress and QoL impairment than men, supporting the need for sex-gender-sensitive interventions.


  • Shared Decision Making in Rheumatology, the Perspective from Mexican Patients and Physicians

    by Irazú Contreras-Yáñez, Guillermo Arturo Guaracha-Basañez, Mariana Lourdes López-Ávila, Abril Verónica Mendoza Vigueras, Frida Carvajal Medina, Loraine Ledón-Llanes, Virginia Pascual-Ramos

    Background: Shared decision-making (SDM) impacts medical and patient-reported outcomes. Objective: The study compared perceptions of SDM between Mexican patients with rheumatic diseases (RMDs) and their attending rheumatologists, identified some factors associated with adequate SDM, and examined the relationship between patient perceptions of SDM and dignity. Patients and Methods: This cross-sectional study was performed between September 2024 and April 2025. Consecutive patients with RMDs completed validated Spanish versions of SDM (SDM-9-Q) and perceived dignity (PDI-Mx). SDM was assessed in the attending rheumatologists with the SDM-Doc-Q. Adequate SDM was defined as a score of ≥72.6 on the SDM-Q-9. Multivariate regression analysis was used. Results: Data from 170 patient-physician encounters were analyzed. Scores of the SDM-9-Q and SDM-Q-Doc showed no differences. However, patients scored higher on items pertaining to the need to decide about the treatment, available treatment options, and related information than doctors did. There were 113 patients (66.5%) with adequate SDM. The duration of underlying RMD [Exp (B): 1.046; 95% CI: 1.008-1.085, p = 0.017] and treatment modifications during encounters [Exp (B): 2.099; 95% CI: 1.073-4.105, p = 0.030] were associated with this outcome. Spearman rho between SDM-9-Q score, SDM-9-Q individual items scores, and the PDI-Mx score was inverse and not significant, but for item 2, related to autonomy principle: rho = -0.160, p = 0.037. Conclusions: Overall perception of SDM was similar between patients with RMDs and their rheumatologists. RMD-related characteristics were associated with patient’ perceptions of adequate SDM, observed in two-thirds of the participants. A weak correlation was observed between patient’s autonomy ideal-related to the SDM process and their perceived dignity.

  • Open Access

    Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis

    by George A Karpouzas, Virginia Pascual-Ramos, Miguel A Gonzalez-Gay, Durga P Misra, Elena Myasoedova, Solbritt Rantapää-Dahlqvist, Petros Sfikakis, Patrick Dessein, Carol A Hitchon, Dionicio Galarza-Delgado, et al.

    Objectives: Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in rheumatoid arthritis (RA). Since disease-related inflammation is linked to cardiovascular risk, we explored whether sex and ACPA influenced the association between disease activity at study entry and cardiovascular risk in established RA. Methods: We evaluated 4008 patients with prevalent RA from an international observational cohort enrolled between 1985 and 2012. Outcomes included major adverse cardiovascular events (MACE: cardiovascular death, myocardial infarction and stroke) and ischaemic cardiovascular events (iCVE: MACE, angina, revascularisation, transient ischaemic attack and peripheral arterial disease). Follow-up accrued from enrolment until the first event or censoring. Multivariable Cox models stratified by centre risk evaluated disease activity, sex, ACPA and their interactions. Results: We documented 193 MACE and 299 iCVE. Disease activity and sex were associated with MACE (all p≤0.017) and iCVE (p≤0.005) but ACPA was only associated with MACE (p=0.043). A three-way interaction on MACE (p=0.034) but not iCVE was noted. Among ACPA-negative patients, disease activity was associated with MACE in males (HR 1.57 (95% CI 1.14 to 2.16)) but not females (p-for-interaction=0.022). Among ACPA-positive patients, neither the disease activity x sex interaction (p=0.929), nor main effect of disease activity on MACE (p=0.124) was significant, but male sex was (HR 1.61 (95% CI 1.15 to 2.27)). Among females, neither disease activity x ACPA interaction (p=0.523) nor disease activity (p=0.319) was significant for MACE, but ACPA was (HR 1.57 (95% CI 1.02 to 2.42)). Conclusions: The effect of disease activity at enrolment on cardiovascular risk in prevalent RA varies across patient groups with different sex and ACPA characteristics.


  • Another look at the intertendinous connections: a dynamic study based on palpation, ultrasonography, and dissection

    by Jorge Murillo-González, Esperanza Naredo, Virginia Pascual-Ramos, José Ramón Mérida-Velasco, Otto Olivas-Vergara, Irazú Contreras-Yáñez, Irene Piñeiro-Bugallo, Arantxa Torres-Rosello, Juan J. Canoso